Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
December 8, 2025Blood

Clonal architecture and dynamics of somatic evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria

View Full Paper
Ask AI
Bookmark
Share

Authors

MCMichael Spencer ChapmanNWNick WilliamsEBE. Joanna Baxter

Discussion

Loading...

Member takes

Overview

Observational analysis uncovered distinct clonal dynamics in aplastic anemia, suggesting new pathways for malignant transformation and treatment response.

Key Points

  • Patients displayed unique evolutionary patterns in aplastic anemia, primarily driven by either immune escape or myeloid factors.
  • Using whole-genome sequencing, somatic mutations were linked to significant differences in clonal architecture and patient outcomes.
  • This analysis revealed novel insights into mutation timing and its separation from immune-mediated selection pressures in disease onset.
  • Enhanced understanding of clonal dynamics in aplastic anemia will aid in optimizing treatment strategies and identifying high-risk patients.

Cite This Study

Chapman et al. (2025) studied this question.

synapsesocial.com/papers/69362f7f4fa91c937236e5f7https://doi.org/10.1182/blood-2025-25
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Molecular gene panel analysis in aplastic anaemia: Diagnostic utility and clinical implications2025
  2. 2Elucidating gene alterations driving hematopoietic dysfunction in PNH via patient-derived ips cell modeling and whole-genome sequencing2025
  3. 3Prognostic significance of PNH clones in aplastic anemia treated with immunosuppression or allogeneic HSCT2025
  4. 4Clonal hematopoiesis and immune dysregulation in classic PNH2025
  5. 5Comprehensive multiproteomic analysis reveals an inflammatory phenotype in immune aplastic anemia characterized by broad activation of antigen presenting cells and t helper/cytotoxic 1.17 immune responses2025